KRAS and cholangiocarcinoma: We showed that MEK inhibitors effectively reduce CCA cell growth in culture and induce apoptosis in a murine CCA model generated by the co-expression of activated mutant forms of K-Ras and Notch1 (KRas/NICD)10.